Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. — ME/CFS Atlas
E2 ModeratePreliminaryPEM not requiredCase-ControlPeer-reviewedReviewed
Standard · 3 min
Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.
Carlo-Stella, N, Bozzini, S, De Silvestri, A et al. · International journal of immunopathology and pharmacology · 2009 · DOI
Quick Summary
This study looked at two genes related to inflammation in 75 Italian ME/CFS patients and compared them to 141 healthy controls. The researchers found that certain genetic variations in the RAGE gene and immune system genes called HLA were more common in ME/CFS patients, suggesting these genetic differences might increase risk for the condition. The findings suggest ME/CFS may involve inherited factors that affect how the immune system responds.
Why It Matters
Understanding the genetic underpinnings of ME/CFS immune dysfunction could eventually help identify at-risk individuals and guide targeted immunomodulatory therapies. This study provides evidence that ME/CFS has a biological, genetic basis involving inflammation regulation, which may help validate the condition and reduce the diagnostic stigma patients face.
Observed Findings
Six RAGE-HLA haplotypes were significantly more frequent in CFS patients, including RAGE-374T/DRB1*04, RAGE-374T/DRB1*09, and RAGE-374T/DRB1*11
HLA-DRB1*1301 was significantly more frequent in CFS patients (13.0% vs 5.1%, OR=2.79)
HLA-DRB1*1104 was significantly less frequent in CFS patients (5.4% vs 12.9%, OR=0.39)
The RAGE-429C/DRB1*07 haplotype showed a protective effect against CFS
Combined RAGE-HLA haplotypes showed stronger associations than single alleles
Inferred Conclusions
Genetic haplotypes combining RAGE and HLA-DRB1 variants, rather than single genes, appear to predispose to or protect against CFS
These genetic factors likely affect immune system regulation and inflammatory responses in ways that increase CFS susceptibility
A synergistic interaction between RAGE polymorphisms and HLA alleles may be involved in CFS pathogenesis
Remaining Questions
Do these genetic variants directly cause increased inflammation in ME/CFS, or do they require environmental triggers (such as infections) to manifest as disease?
How do identified RAGE-HLA haplotypes mechanistically alter immune response and inflammation regulation in ME/CFS patients?
What This Study Does Not Prove
This study does not prove that these genetic variants cause ME/CFS—only that they are associated with it. It does not establish whether genetic predisposition directly leads to ME/CFS or requires environmental triggers. The findings are limited to an Italian population and may not apply to other ethnic groups; replication in diverse populations is needed.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Do these findings replicate in other ethnic populations, and are there additional genetic variants or subregions within HLA that contribute to CFS risk?
Can genetic testing based on these haplotypes help predict who will develop ME/CFS after illness or guide personalized treatment strategies?